Hepatotoxicity of immune checkpoint inhibitors: An evolving picture of risk associated with a vital class of immunotherapy agents-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hepatotoxicity of immune checkpoint inhibitors: An evolving picture of risk associated with a vital class of immunotherapy agents

Published:2018-04-24 Issue:6 Volume:38 Page:976-987
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Suzman Daniel L.¹,Pelosof Lorraine¹,Rosenberg Amy²,Avigan Mark I.³

Affiliation:

1. Office of Hematology and Oncology Products; Center for Drug Evaluation and Research; US Food and Drug Administration; Silver Spring MD USA

2. Office of Biotechnology Products; Center for Drug Evaluation and Research; US Food and Drug Administration; Silver Spring MD USA

3. Office of Surveillance and Epidemiology; Center for Drug Evaluation and Research; US Food and Drug Administration; Silver Spring MD USA

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13746/fullpdf

Reference99 articles.

1. The journey from discoveries in fundamental immunology to cancer immunotherapy;Miller Jacques;Cancer Cell,2015

2. The future of cancer treatment: immunomodulation, CARs and combination immunotherapy;Khalil;Nat Rev Clin Oncol,2016

3. Cancer immunotherapy: opportunities and challenges in the rapidly evolving clinical landscape;Emens;Eur J Cancer,2017

4. Introduction to checkpoint inhibitors and cancer immunotherapy;Sharpe;Immunol Rev,2017

5. The next immune-checkpoint inhibitors: PD-1/PD-L1 blockade in melanoma;Mahoney;Clin Ther,2015

Cited by 174 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking immunotherapy targets: programmed death 1 and its ligand and their correlation with tumour grade in feline injection site sarcoma;Journal of Comparative Pathology;2024-08

2. Hepatobiliary complications of immune checkpoint inhibitors in cancer;Exploration of Targeted Anti-tumor Therapy;2024-07-26

3. The Epidemiology of Newly Recognized Causes of Drug-Induced Liver Injury: An Update;Pharmaceuticals;2024-04-18

4. Clinical characteristics and prognostic implications of immune-related hepatitis in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors: a retrospective study;J THORAC DIS;2024

5. Pancreatic injury in patients treated with immune checkpoint inhibitors: a retrospective multicenterstudy;Journal of Gastroenterology;2024-02-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3